title: Subcutaneous panniculitis-like T-cell lymphoma in a patient receiving etanercept for rheumatoid arthritis.
authors.forename: C
authors.initials: C
authors.lastname: Michot
authors.forename: V
authors.initials: V
authors.lastname: Costes
authors.forename: D
authors.initials: D
authors.lastname: Gerard-Dran
authors.forename: B
authors.initials: B
authors.lastname: Guillot
authors.forename: B
authors.initials: B
authors.lastname: Combes
authors.forename: O
authors.initials: O
authors.lastname: Dereure
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D016399:Lymphoma, T-Cell / Q000139:chemically induced* / Q000473:pathology; D008875:Middle Aged; D015434:Panniculitis / Q000139:chemically induced; D018124:Receptors, Tumor Necrosis Factor; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept